DCM Advisors’s Exelixis EXEL Stock Holding History

DCM Advisors’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-18,000	Closed	-$375K	–	190
2022 Q2	$375K	Buy	+18,000	New	+$371K	0.16%	129

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

DCM Advisors's EXEL Position: Q3 2022 in Review

DCM Advisors sold out of Exelixis (EXEL) in Q3 2022, closing a stake of 18,000 shares — an estimated $375K sold.

DCM Advisors first reported a position in EXEL in Q2 2022 and held it in 1 quarter. The position peaked at $375K in Q2 2022. 400 funds tracked by Wall St. Rank hold EXEL as of Q3 2022.

DCM Advisors reported no remaining Exelixis position as of Q3 2022 after selling out during the quarter.
DCM Advisors sold 18,000 Exelixis shares in Q3 2022, an estimated $375K.
DCM Advisors first reported a position in Exelixis in Q2 2022 and held it in 1 quarter.
DCM Advisors's Exelixis position peaked at $375K in Q2 2022.
400 funds tracked by Wall St. Rank held Exelixis as of Q3 2022.

Based on DCM Advisors's 13F filing for Q3 2022, filed 11 Sep 2023.